Where Elpis Biosciences comes from, what we believe, and where we're going.
Someone close to us lives with multiple chronic conditions. She has experienced what it feels like to not be believed — the appointments that end without answers, the tests that come back normal, the quiet dismissals that accumulate over years of navigating a healthcare system not designed to handle ambiguity well.
We went looking for genetic tools that could help. What we found were reports full of confident-sounding language with no citations, trait predictions wrapped in vague disclaimers, and companies treating genetic data as an asset to be monetized. Elpis Biosciences is the reaction to all of that.
"We watched 23andMe enter bankruptcy proceedings with millions of people's genetic data as a line item on a balance sheet. That is not what trust looks like."
Elpis's current reports are Research Use Only — educational tools that give you better questions to bring to your provider. The longer-term goal is diagnostic-grade. Tools specific enough and robust enough to be taken directly to a healthcare provider and acted on with confidence.
The free parser is the foundation of that trust. We want to earn the right to build the harder thing by doing this simpler thing well. This is version one. We're building in the open, and we're building it with you.